Found: 32
Select item for more details and to access through your institution.
Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter Study.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 6, p. 1, doi. 10.1093/ofid/ofad307
- By:
- Publication type:
- Article
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 2, p. 827, doi. 10.1007/s40121-021-00424-8
- By:
- Publication type:
- Article
Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE).
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19785
- By:
- Publication type:
- Article
Safety of rilpivirine plus nucleoside reverse-transcriptase inhibitors in HIV-infected Taiwanese with a higher prevalence of hepatitis virus infection.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19580
- By:
- Publication type:
- Article
Lipid-lowering agents for dyslipidemia in patients who were infected with HIV in Taoyuan, Taiwan.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19556
- By:
- Publication type:
- Article
Highly Active Antiretroviral Therapy is Associated with Decreased Incidence of Sexually Transmitted Diseases in a Taiwanese HIV-Positive Population.
- Published in:
- AIDS Patient Care & STDs, 2013, v. 27, n. 3, p. 155, doi. 10.1089/apc.2012.0385
- By:
- Publication type:
- Article
The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 6, p. 1, doi. 10.1371/journal.ppat.1012246
- By:
- Publication type:
- Article
Screening and risk factors for anal cancer precursors in men infected with HIV in Taiwan.
- Published in:
- Journal of Medical Virology, 2014, v. 86, n. 2, p. 193, doi. 10.1002/jmv.23825
- By:
- Publication type:
- Article
Influence of age and CD4+ T cell counts on the prevalence of genital human papillomavirus infection among HIV-seropositive men who have sex with men in Taiwan.
- Published in:
- Journal of Medical Virology, 2012, v. 84, n. 12, p. 1876, doi. 10.1002/jmv.23413
- By:
- Publication type:
- Article
Hepatitis B surface antigen confirmatory testing for diagnosis of hepatitis b virus infection in Taiwan.
- Published in:
- Journal of Medical Virology, 2011, v. 83, n. 9, p. 1514, doi. 10.1002/jmv.22127
- By:
- Publication type:
- Article
Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
- Published in:
- Journal of Medical Virology, 2009, v. 81, n. 6, p. 973, doi. 10.1002/jmv.21481
- By:
- Publication type:
- Article
Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan.
- Published in:
- Journal of Medical Virology, 2008, v. 80, n. 2, p. 183, doi. 10.1002/jmv.21065
- By:
- Publication type:
- Article
A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 18, doi. 10.3390/vaccines11010018
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Heterologous Booster of Protein Subunit Vaccine MVC-COV1901 after Two Doses of Adenoviral Vector Vaccine AZD1222.
- Published in:
- Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101701
- By:
- Publication type:
- Article
An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 655, doi. 10.3390/vaccines10050655
- By:
- Publication type:
- Article
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22446-z
- By:
- Publication type:
- Article
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22446-z
- By:
- Publication type:
- Article
Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 5, p. 943, doi. 10.1007/s10147-015-0804-9
- By:
- Publication type:
- Article
Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0073069
- By:
- Publication type:
- Article
Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 2, p. 1, doi. 10.1371/journal.ppat.1009352
- By:
- Publication type:
- Article
Predicting Emotional Valence of People Living with the Human Immunodeficiency Virus Using Daily Voice Clips: A Preliminary Study.
- Published in:
- Healthcare (2227-9032), 2021, v. 9, n. 9, p. 1148, doi. 10.3390/healthcare9091148
- By:
- Publication type:
- Article
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0242763
- By:
- Publication type:
- Article
Incidence and Risk Factors of Reinfection with HCV after Treatment in People Living with HIV.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 2, p. 439, doi. 10.3390/v14020439
- By:
- Publication type:
- Article
Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in Taiwan: a multicenter cohort study.
- Published in:
- Infection & Drug Resistance, 2018, v. 11, p. 849, doi. 10.2147/IDR.S158341
- By:
- Publication type:
- Article
Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0171596
- By:
- Publication type:
- Article
Clostridium difficile—Associated Diseases: Comparison of Symptomatic Infection Versus Carriage on the Basis of Risk Factors, Toxin Production, and Genotyping Results.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. 1, p. 157
- By:
- Publication type:
- Article
The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194149
- By:
- Publication type:
- Article
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186338
- By:
- Publication type:
- Article
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179870
- By:
- Publication type:
- Article